Join
Live feed
·
PRReleasevia Quantisnow
PMGC Holdings Inc. logo

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

ByQuantisnow·Wall Street's wire, on your screen.
ELAB· PMGC Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELAB (PMGC Holdings Inc.) and more on Quantisnow.